Skip to content

Omnicell OMCL Other current assets

Other current assets at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$1.43B+24.5%
Cardinal Health logo
Cardinal HealthCAH
$2.47B+3.1%
Guardian Pharmacy Services logo
Guardian Pharmacy ServicesGRDN
ICU Medical logo
ICU MedicalICUI
Solventum logo
SolventumSOLV
Medline, Inc.
 logo
Medline, Inc. MDLN

Other financials

Income statement

See full
Revenue$309.9M+14.9%
Gross profit$140.4M+26.5%
Operating income$16.9M+245%
Net income$11.4M+262%
EPS (diluted)$0.25+267%

Balance sheet

See full
Cash & equivalents$291.0M-29.8%
Total debt$34.3M-23.1%
Total equity$1.3B0.0%
Total assets$2.0B-6.8%

Cash flow

See full
Operating cash flow$54.5M+110%
CapEx$12.4M+11.3%
Free cash flow$42.1M+185%

Valuation

See full
Market cap$1.8B-7.2%

Profitability

See full
Gross margin43.5%+0.4pp
Operating margin2.7%+1.8pp
Net margin1.7%+1.1pp
FCF margin9.3%-1.7pp

Returns & leverage

See full
Return on equity1.6%+1.1pp
Debt / equity0.0×
Current ratio1.5×+0.1×

Where this comes from

Reported directly by Omnicell in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.

The official record: Omnicell’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Omnicell's other current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Omnicell's other current assets?
Omnicell (OMCL) reported other current assets of $100.43M in Q1 2026.
How has Omnicell's other current assets changed year-over-year?
Omnicell's other current assets increased by 20.5% year-over-year, from $83.35M to $100.43M.
What is the long-term trend for Omnicell's other current assets?
Over 5 years (2020 to 2025), Omnicell's other current assets has grown at a 26.3% compound annual growth rate (CAGR), from $41.04M to $132.08M.